Our Pricing

Mounjaro Broadstairs: Your Complete Guide to Local Access and Pricing

Published: 4 October 2026

Residents searching for Mounjaro Broadstairs now have convenient access to this clinically proven weight loss treatment through Cured Pharmacy, a fully UK-registered online service offering tirzepatide injections from £124.99. Our platform connects Broadstairs patients with GMC-registered prescribers for fast, discreet assessment and next-day delivery across Kent, eliminating the need for in-person pharmacy visits while maintaining full clinical safety and MHRA compliance.

What Is Mounjaro Broadstairs and How Does It Work?

Mounjaro Broadstairs refers to the availability of Mounjaro (tirzepatide) weight loss injections for residents of Broadstairs and the wider Kent area through registered UK online pharmacies like Cured Pharmacy. Tirzepatide is a dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes or hypertension[1].

The medication works by mimicking two naturally occurring hormones that regulate appetite and blood sugar. In the landmark SURMOUNT-1 trial, participants achieved an average weight reduction of 20.9% over 72 weeks when using the highest maintenance dose alongside lifestyle interventions[2]. Mounjaro is administered once weekly via a pre-filled KwikPen injector, making it a convenient option for Broadstairs residents seeking effective, evidence-based weight management without daily medication routines.

At Cured Pharmacy, every Mounjaro prescription begins with a free online consultation completed by a UK-registered prescriber. This ensures the treatment is clinically appropriate for your individual health profile, with full consideration of contraindications, current medications, and weight loss goals. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all dispensing to guarantee you receive genuine, UK-licensed Mounjaro delivered discreetly to your Broadstairs address.

Mounjaro Broadstairs Pricing and How to Save £10 on Your First Order

Mounjaro Broadstairs is available from Cured Pharmacy at £124.99 per prescription, representing some of the most competitive pricing in the UK market for tirzepatide injections. We believe in transparent, upfront pricing—you'll see the exact cost before completing your clinical assessment, with no hidden fees or surprise charges at checkout.

New patients can Save £20 on their first Mounjaro order by using the code Weightlossnew during checkout, reducing the initial cost to £124.99. This discount applies automatically when you complete your online consultation and receive prescriber approval. Unlike high-street pharmacies in Broadstairs that may require multiple in-person appointments and longer wait times, our streamlined digital service delivers your prescription directly to your door, often within 24 hours of approval.

All Mounjaro prescriptions dispensed by Cured Pharmacy are subject to clinical assessment by a GMC-registered prescriber. Pricing includes the medication, consultation, prescriber review, and discreet home delivery across Broadstairs, Ramsgate, Margate, and all CT postcodes in Kent. We guarantee the lowest UK prices and will match any verified lower quote from another registered pharmacy.

Transparent Costs with No Hidden Fees

Many patients in Broadstairs appreciate that Cured Pharmacy displays all costs before the consultation process begins. There are no membership fees, no recurring subscriptions unless you choose ongoing treatment, and no additional delivery charges for standard next-day service. your £20 payment covers everything required to receive genuine Mounjaro safely and legally in the UK.

How to Order Mounjaro Broadstairs Online in Under 3 Minutes

Ordering Mounjaro Broadstairs through Cured Pharmacy is designed to be fast, secure, and entirely online. Start by completing our free medical questionnaire, which takes under three minutes and covers your weight loss history, current medications, allergies, and any existing health conditions. This information is reviewed by a UK-registered prescriber who will determine whether Mounjaro is clinically suitable for you.

Once approved, your prescription is sent electronically to our GPhC-registered pharmacy (9012511) where it is dispensed by our qualified team under the supervision of superintendent pharmacist Tarun Kumar. Your Mounjaro is then packaged discreetly—no external branding or medication names visible—and dispatched via tracked courier for next-day delivery to your Broadstairs address. You'll receive email and SMS updates at every stage, from prescriber review to dispatch.

If the prescriber determines that Mounjaro is not appropriate based on your medical history, they may suggest alternative treatments such as Wegovy (semaglutide) or Saxenda (liraglutide), both available through the same streamlined process. No payment is taken until your prescription is approved, ensuring you only pay for treatments deemed safe and effective for your individual circumstances.

Fast Delivery Across Broadstairs and Kent

Cured Pharmacy offers next-day delivery to all Broadstairs postcodes (CT10) and the wider Kent region, including Ramsgate, Margate, Canterbury, and Dover. Orders approved before 3pm on weekdays are typically dispatched the same day, arriving the following morning in plain, discreet packaging. For patients requiring ongoing treatment, we offer convenient repeat prescription services with automatic reminders when your next dose is due.

Mounjaro Broadstairs Dosing Schedule and What to Expect

Mounjaro Broadstairs follows a carefully structured dose escalation schedule designed to minimise gastrointestinal side effects while maximising weight loss efficacy. Treatment begins with a 2.5mg dose administered once weekly for the first four weeks, serving as an initial tolerability phase rather than a therapeutic dose[3]. After this period, the dose increases to 5mg weekly, with further increases every four weeks (7.5mg, 10mg, 12.5mg, and finally 15mg) based on individual response and tolerability.

Clinical trial data from the SURMOUNT studies indicate that higher maintenance doses (12.5mg and 15mg) are associated with greater average weight reduction, though many patients achieve significant results at lower doses[2]. Your prescriber will work with you to identify the optimal maintenance dose that balances efficacy with side effect management. Each Mounjaro KwikPen is pre-filled and single-use, eliminating the need for manual dose measurement or needle assembly.

Common side effects during the escalation phase include nausea, diarrhoea, and reduced appetite—these typically diminish as your body adjusts to each new dose level. Broadstairs patients using Mounjaro through Cured Pharmacy have access to ongoing clinical support via our patient portal, where you can message prescribers with questions or concerns about side effects, dosing, or progress. Adjustments to your dose escalation timeline can be made if needed to improve tolerability.

Who Can Use Mounjaro Broadstairs? Eligibility and Contraindications

Mounjaro Broadstairs is licensed for adults aged 18 and over with a BMI of 30 kg/m² or higher, or 27 kg/m² or higher with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea[1]. The treatment is intended for use alongside a reduced-calorie diet and increased physical activity, not as a standalone solution. Your online consultation will assess your BMI, medical history, and weight loss goals to determine eligibility.

Certain conditions contraindicate Mounjaro use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic ketoacidosis. Pregnant or breastfeeding individuals should not use tirzepatide, and women of childbearing potential are advised to use effective contraception during treatment and for at least four weeks after discontinuation. Your prescriber will review all contraindications during the assessment process.

Patients in Broadstairs currently taking other GLP-1 receptor agonists (such as Wegovy, Saxenda, or Ozempic) should not use Mounjaro concurrently due to overlapping mechanisms of action and increased risk of adverse effects. If you are already using another weight loss medication, inform your prescriber during the consultation so they can advise on safe transition protocols or alternative treatment options. All clinical decisions are made by UK-registered prescribers in accordance with MHRA and NICE guidance.

Special Considerations for Broadstairs Patients

Residents of Broadstairs with pre-existing diabetes, cardiovascular conditions, or thyroid disorders require additional clinical review before starting Mounjaro. Our prescribers will request relevant medical history and may liaise with your NHS GP to ensure safe, coordinated care. Cured Pharmacy operates under full GPhC and CQC oversight, ensuring every prescription meets the highest standards of patient safety and clinical governance.

Mounjaro Broadstairs vs Other Weight Loss Treatments Available Locally

When considering Mounjaro Broadstairs, many patients also evaluate alternative treatments such as Wegovy (semaglutide), Saxenda (liraglutide), and oral options like Orlistat. Mounjaro's dual GIP/GLP-1 mechanism distinguishes it from single-agonist therapies, with head-to-head trials demonstrating superior average weight loss compared to semaglutide 1mg in the SURPASS-2 study[4]. However, individual response varies, and some patients may prefer the lower starting cost or different side effect profile of alternatives.

Wegovy, available from Cured Pharmacy at £124.99, is another highly effective GLP-1 receptor agonist that achieved an average 14.9% weight reduction in the STEP-1 trial[5]. Saxenda, priced from £124.99, requires daily injections rather than weekly, which some Broadstairs patients find less convenient. For those seeking non-injection options, Orlistat (from £124.99) works by blocking fat absorption but typically produces more modest weight loss (average 5-10%) and requires strict dietary fat restriction to minimise gastrointestinal side effects.

The choice between Mounjaro Broadstairs and alternative treatments depends on your clinical profile, budget, lifestyle preferences, and weight loss goals. Our prescribers can discuss the evidence base for each option during your consultation, helping you make an informed decision. Many patients begin with one treatment and adjust based on results and tolerability, with ongoing prescriber support available throughout your weight management journey.

Combining Mounjaro with Lifestyle Changes in Broadstairs

Clinical trials consistently show that Mounjaro is most effective when combined with dietary modification and increased physical activity[2]. Broadstairs offers excellent opportunities for active living, from coastal walks along Viking Bay to local fitness facilities and community sports clubs. Our patient resources include evidence-based nutrition guidance and exercise recommendations tailored to complement your tirzepatide treatment, optimising long-term weight management outcomes.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 4 October 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 4 October 2026]
3. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity: Technology appraisal guidance. NICE. [accessed 4 October 2026]
4. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 4 October 2026]
5. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 4 October 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 4 October 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 4 October 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 4 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.